| pubmed-article:12924538 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12924538 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:12924538 | lifeskim:mentions | umls-concept:C0031327 | lld:lifeskim |
| pubmed-article:12924538 | lifeskim:mentions | umls-concept:C0525005 | lld:lifeskim |
| pubmed-article:12924538 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
| pubmed-article:12924538 | lifeskim:mentions | umls-concept:C1521761 | lld:lifeskim |
| pubmed-article:12924538 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:12924538 | pubmed:dateCreated | 2003-8-19 | lld:pubmed |
| pubmed-article:12924538 | pubmed:abstractText | The study describes the pharmacokinetics (PK) of the protease inhibitor nelfinavir and its active metabolite M8 in children and evaluates the influence of patient-related factors on nelfinavir plasma levels. | lld:pubmed |
| pubmed-article:12924538 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12924538 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12924538 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12924538 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12924538 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12924538 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12924538 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12924538 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:12924538 | pubmed:issn | 1359-6535 | lld:pubmed |
| pubmed-article:12924538 | pubmed:author | pubmed-author:BurgerDavid... | lld:pubmed |
| pubmed-article:12924538 | pubmed:author | pubmed-author:de... | lld:pubmed |
| pubmed-article:12924538 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:12924538 | pubmed:author | pubmed-author:WolfsTom F... | lld:pubmed |
| pubmed-article:12924538 | pubmed:author | pubmed-author:GeelenSibyl... | lld:pubmed |
| pubmed-article:12924538 | pubmed:author | pubmed-author:FraaijPieter... | lld:pubmed |
| pubmed-article:12924538 | pubmed:author | pubmed-author:BergshoeffAli... | lld:pubmed |
| pubmed-article:12924538 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12924538 | pubmed:volume | 8 | lld:pubmed |
| pubmed-article:12924538 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12924538 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12924538 | pubmed:pagination | 215-22 | lld:pubmed |
| pubmed-article:12924538 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:12924538 | pubmed:meshHeading | pubmed-meshheading:12924538... | lld:pubmed |
| pubmed-article:12924538 | pubmed:meshHeading | pubmed-meshheading:12924538... | lld:pubmed |
| pubmed-article:12924538 | pubmed:meshHeading | pubmed-meshheading:12924538... | lld:pubmed |
| pubmed-article:12924538 | pubmed:meshHeading | pubmed-meshheading:12924538... | lld:pubmed |
| pubmed-article:12924538 | pubmed:meshHeading | pubmed-meshheading:12924538... | lld:pubmed |
| pubmed-article:12924538 | pubmed:meshHeading | pubmed-meshheading:12924538... | lld:pubmed |
| pubmed-article:12924538 | pubmed:meshHeading | pubmed-meshheading:12924538... | lld:pubmed |
| pubmed-article:12924538 | pubmed:meshHeading | pubmed-meshheading:12924538... | lld:pubmed |
| pubmed-article:12924538 | pubmed:meshHeading | pubmed-meshheading:12924538... | lld:pubmed |
| pubmed-article:12924538 | pubmed:meshHeading | pubmed-meshheading:12924538... | lld:pubmed |
| pubmed-article:12924538 | pubmed:meshHeading | pubmed-meshheading:12924538... | lld:pubmed |
| pubmed-article:12924538 | pubmed:meshHeading | pubmed-meshheading:12924538... | lld:pubmed |
| pubmed-article:12924538 | pubmed:meshHeading | pubmed-meshheading:12924538... | lld:pubmed |
| pubmed-article:12924538 | pubmed:meshHeading | pubmed-meshheading:12924538... | lld:pubmed |
| pubmed-article:12924538 | pubmed:meshHeading | pubmed-meshheading:12924538... | lld:pubmed |
| pubmed-article:12924538 | pubmed:meshHeading | pubmed-meshheading:12924538... | lld:pubmed |
| pubmed-article:12924538 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12924538 | pubmed:articleTitle | Pharmacokinetics of nelfinavir in children: influencing factors and dose implications. | lld:pubmed |
| pubmed-article:12924538 | pubmed:affiliation | University Medical Centre, Department of Clinical Pharmacy, Nijmegen, The Netherlands. A.Bergshoeff@akf.umcn.nl | lld:pubmed |
| pubmed-article:12924538 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12924538 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12924538 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12924538 | lld:pubmed |
